Stepwise Blood Pressure Reduction for 150/90 mmHg
For blood pressure of 150/90 mmHg (Grade 1 hypertension), start lifestyle interventions immediately and initiate drug therapy now if you have high cardiovascular risk (CVD, CKD, diabetes, organ damage, or age 50-80 years); otherwise, start medication after 3-6 months if BP remains elevated despite lifestyle changes. 1
Immediate Actions
Confirm the Diagnosis
- Take at least 2 more BP readings at this visit using a validated device with appropriate cuff size 1
- Confirm with home BP monitoring (≥135/85 mmHg confirms hypertension) or 24-hour ambulatory monitoring (≥130/80 mmHg confirms hypertension) 1
- Remeasure in 2-3 office visits before finalizing diagnosis 1
Start Lifestyle Modifications Now (All Patients)
- Sodium restriction: Limit intake to <2g/day, which can reduce BP by 5-10 mmHg 1, 2
- Weight loss: Target BMI 20-25 kg/m² if overweight 1
- Physical activity: Regular aerobic exercise (150 minutes/week moderate intensity) 3, 4
- Dietary pattern: Adopt DASH diet emphasizing fruits, vegetables, low-fat dairy, reduced saturated fat 3
- Alcohol limitation: <100g/week 1
- Potassium supplementation: Increase dietary potassium intake 2, 3
These lifestyle changes provide additive BP reductions of 10-20 mmHg and enhance medication efficacy 1, 2
Drug Therapy Algorithm
Step 1: Initial Monotherapy
For Non-Black Patients:
- Start low-dose ACE inhibitor (e.g., lisinopril 10mg daily) OR ARB (e.g., losartan 50mg daily) 1, 5
- Alternative: Low-dose calcium channel blocker (amlodipine 5mg daily) 1
For Black Patients:
- Start low-dose ARB PLUS dihydropyridine calcium channel blocker (e.g., amlodipine 5mg) 1
- Alternative: Calcium channel blocker plus thiazide-like diuretic 1
Step 2: Increase to Full Dose (If BP Still Elevated After 2-4 Weeks)
- Uptitrate ACE inhibitor/ARB to maximum dose (e.g., lisinopril 40mg, losartan 100mg) 1
- OR uptitrate calcium channel blocker to full dose (amlodipine 10mg) 1
Step 3: Add Second Agent (Dual Therapy)
For Non-Black Patients:
- Add dihydropyridine calcium channel blocker (amlodipine 5-10mg) to ACE inhibitor/ARB 1, 6
- Alternative: Add thiazide-like diuretic (chlorthalidone 12.5-25mg or hydrochlorothiazide 25mg) 1, 6
For Black Patients:
- If started on CCB + diuretic, add ARB or ACE inhibitor 1
- If started on ARB + CCB, add thiazide-like diuretic 1
Step 4: Triple Therapy (If BP Still Uncontrolled)
- Combine ACE inhibitor/ARB + calcium channel blocker + thiazide-like diuretic at full doses 1, 6
- This represents guideline-recommended triple therapy with complementary mechanisms 6
Step 5: Resistant Hypertension (Fourth Agent)
- Add spironolactone 25-50mg daily as preferred fourth-line agent 1, 6
- Alternatives if spironolactone not tolerated: amiloride, doxazosin, eplerenone, clonidine, or beta-blocker 1
Blood Pressure Targets
- Initial goal: Reduce BP by at least 20/10 mmHg 1, 5
- Primary target: <140/90 mmHg for most patients 1, 2
- Optimal target: <130/80 mmHg for higher-risk patients (diabetes, CKD, CVD) 1, 6
- Timeline: Achieve target within 3 months of starting or modifying therapy 1, 6
Monitoring Schedule
- Week 2-4: Reassess BP after initiating or changing medication 1, 6
- Check labs: Serum potassium and creatinine 2-4 weeks after starting ACE inhibitor/ARB or diuretic 6
- Home BP monitoring: Use to confirm control and improve adherence 5
- Follow-up visits: Every 2-4 weeks until target achieved, then every 3-6 months 1
Critical Pitfalls to Avoid
- Don't delay treatment in high-risk patients (CVD, CKD, diabetes, organ damage, age 50-80)—start medication immediately 1, 5
- Don't combine ACE inhibitor with ARB—increases adverse events without benefit 6
- Don't add beta-blocker as routine second or third agent unless compelling indication (angina, post-MI, heart failure, rate control needed) 6
- Don't assume treatment failure without first confirming medication adherence and ruling out secondary hypertension 6
- Don't use non-dihydropyridine CCBs (diltiazem, verapamil) if heart failure present 6
When to Refer to Specialist
- BP remains ≥160/100 mmHg despite 4-drug therapy at optimal doses 1, 6
- Suspected secondary hypertension (young age, sudden onset, resistant hypertension) 5
- Multiple drug intolerances 6
- Concerning features requiring specialized evaluation 1
Medication-Specific Monitoring
ACE Inhibitors/ARBs:
- Monitor for cough (ACE inhibitors), hyperkalemia, acute kidney injury 6
- Check potassium and creatinine 1-4 weeks after initiation or dose increase 6
Thiazide Diuretics:
- Monitor for hypokalemia, hyperuricemia, glucose intolerance 6
- Chlorthalidone preferred over hydrochlorothiazide due to longer duration of action 6, 7
Calcium Channel Blockers:
- Monitor for peripheral edema (may be attenuated by adding ACE inhibitor/ARB) 6